Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1276238

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1276238

U.S. Clinical Nutrition Market - By Product, By Consumer, By Application, Distribution Channel, Dosage Formulation & Forecast, 2023 - 2032

PUBLISHED:
PAGES: 90 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2550
PDF & Excel (Multi User License)
USD 3050
PDF & Excel (Enterprise User License)
USD 5050

Add to Cart

U.S. Clinical Nutrition Market will exhibit robust growth during 2023-2032, attributed to the growing prevalence of chronic disorders and high consumption of junk food.

Junk food consumption has increased dramatically in recent years due to hectic lifestyles and a high preference for fast food. However, this scenario has aggravated health concerns, particularly across Western nations, with growing incidences of malnourishment and nutrient deficiencies. Fast foods lack a rich nutritional profile and are devoid of vitamins. As per the USDA, in December 2021, spending across limited-service and full-service restaurants were 10% higher than in December 2019.

Majority of young adults and children in the U.S. eat junk food, resulting in a lack of essential nutrients causing deficiencies and poor growth. According to a survey conducted by the National Center for Health Statistics in 2022, more than 36.5% of the American adult population consumes junk food on any given day.

The market is segmented into product, consumer, application, distribution channel, and dosage formulation.

Based on product, the U.S. clinical nutrition market share from enteral nutrition exceeded USD 4 billion in 2022. The increasing patient pool of chronic diseases is expected to drive the demand for enteral nutrition products, which are administered to patients in an ICU, CCU, and other home care settings. These products offer myriad advantages, including optimization of gut function, improvement of insulin sensitivity & glycemic control, and the ability to overcome nutritional deficiencies.

In terms of consumer, the industry is segmented into adult and pediatric. Among these, the demand for clinical nutrition among adult consumers is set to rise notably over 2032, driven by the growing concerns associated with malnutrition. The aging population is more susceptible to nutritional deficiencies, and aging-related metabolic disorders such as cardiac and chronic nutritional imbalance, and renal, and liver problems.

With regards to application, the market is classified into gastrointestinal disorders, metabolic disorders, neurological disorders, cancer, and others. The gastrointestinal disorders segment will surpass USD 7.8 billion by 2032 due to the rising prevalence of gut health issues among undernourished patients. Lack of adequate nutrition is a major cause of gastrointestinal conditions such as stomach cramping, discomfort, slow gastric emptying, bloating, excessive infusion rate, and constipation. Patients with severe or chronic GI disorders often suffer from protein or calorie malnutrition, driving the need for clinical nutrition, and supplementation.

Based on distribution channel, the industry is bifurcated into retail stores, online channels, pharmacies & drug stores, and others. Retail stores held over 40% of the U.S. clinical nutrition market share in 2022. Several consumers prefer retail stores as they offer easy access to an array of supplements designed to address different nutritional needs. Moreover, the increasing efforts by retail giants worldwide to expand their geographic footprint will spur industry growth.

Product Code: 4514

Table of Contents

Chapter 1 Methodology

  • 1.1 Industry coverage
  • 1.2 Market scope & definitions
  • 1.3 Base estimates & working
    • 1.3.1 Data collection
  • 1.4 Forecast parameters
  • 1.5 COVID-19 impact analysis at country level
  • 1.6 Data validation
  • 1.7 Data sources
    • 1.7.1 Primary
    • 1.7.2 Secondary
      • 1.7.2.1 Paid sources
      • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Business trends

Chapter 3 US Clinical Nutrition Industry Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing metabolic disorders and other chronic diseases
      • 3.2.1.2 High junk food consumption leading to malnourishment
      • 3.2.1.3 Rising geriatric population
      • 3.2.1.4 Increasing incidence of pre-mature birth & birth rate
      • 3.2.1.5 Increasing adoption of home healthcare
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Stringent government regulations
  • 3.3 Growth potential analysis
    • 3.3.1 By product
    • 3.3.2 By consumer
    • 3.3.3 By application
    • 3.3.4 By distribution channel
    • 3.3.5 By dosage formulation
  • 3.4 COVID-19 impact analysis
  • 3.5 Key market trends
  • 3.6 Technology landscape
  • 3.7 Supply chain analysis for clinical nutrition
  • 3.8 Dietary supplements usage scenario in U.S.
  • 3.9 Regulatory landscape
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Strategy dashboard, 2022

Chapter 5 US Clinical Nutrition Market, By Product

  • 5.1 Key product trends
  • 5.2 Infant nutrition
    • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.2 Milk based
      • 5.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.3 Soy based
      • 5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.4 Organic formulas
      • 5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.5 Others
      • 5.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.3 Enteral nutrition
    • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.2 Standard composition
      • 5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.3 Disease specific composition
      • 5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.4 Parenteral nutrition
    • 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.4.2 Amino acids
      • 5.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.4.3 Fats
      • 5.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.4.4 Carbohydrates
      • 5.4.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.4.5 Others
      • 5.4.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 US Clinical Nutrition Market, By Consumer

  • 6.1 Key consumer trends
  • 6.2 Pediatric
    • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.3 Adult
    • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 US Clinical Nutrition Market, By Application

  • 7.1 Key application trends
  • 7.2 Cancer
    • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.3 Metabolic disorders
    • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.4 Neurological diseases
    • 7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.5 Gastrointestinal disorders
    • 7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.6 Others
    • 7.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 US Clinical Nutrition Market, By Distribution Channel

  • 8.1 Key distribution channel trends
  • 8.2 Retail stores
    • 8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.3 Pharmacies & drug stores
    • 8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.4 Online channels
    • 8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.5 Others
    • 8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9 US Clinical Nutrition Market, By Dosage Formulation

  • 9.1 Key dosage formulation trends
  • 9.2 Powder
    • 9.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 9.3 Liquid
    • 9.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 9.4 Solid
    • 9.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 10 Company Profiles

  • 10.1 Abbott Laboratories (Abbott Nutrition)
  • 10.2 B Braun Melsungen AG
  • 10.3 Baxter International Inc.
  • 10.4 Fresenius Kabi
  • 10.5 Mead Johnson (Reckitt Benckiser)
  • 10.6 Nestle Health Science
  • 10.7 Perrigo
  • 10.8 Pfizer, Inc.
  • 10.9 Danone
  • 10.10 Hero Nutritionals Inc.
  • 10.11 Aculife Healthcare Pvt Ltd
  • 10.12 Hormel Foods Corporation
  • 10.13 BASF SE
  • 10.14 Meiji Holdings Co Ltd.
  • 10.15 Grifols SA
Product Code: 4514

Data Tables

  • TABLE 1 Product mapping
  • TABLE 2 Market revenue, by product (2022)
  • TABLE 3 Market share, by consumer (2022)
  • TABLE 4 Market revenue, by application (2022)
  • TABLE 5 Market share, by distribution channel (2022)
  • TABLE 6 Market revenue, by dosage formulation (2022)
  • TABLE 7 U.S. clinical nutrition market, 2018 - 2024 (USD Million)
  • TABLE 8 U.S. clinical nutrition market, 2025 - 2032 (USD Million)
  • TABLE 9 Industry impact forces
  • TABLE 10 Infant nutrition market, 2018 - 2024, (USD Million)
  • TABLE 11 Infant nutrition market, 2025 - 2032, (USD Million)
  • TABLE 12 Milk based market, 2018 - 2024, (USD Million)
  • TABLE 13 Milk based market, 2025 - 2032, (USD Million)
  • TABLE 14 Soy based market, 2018 - 2024, (USD Million)
  • TABLE 15 Soy based market, 2025 - 2032, (USD Million)
  • TABLE 16 Organic formulas market, 2018 - 2024, (USD Million)
  • TABLE 17 Organic formulas market, 2025 - 2032, (USD Million)
  • TABLE 18 Others market, 2018 - 2024, (USD Million)
  • TABLE 19 Others market, 2025 - 2032, (USD Million)
  • TABLE 20 Enteral nutrition market, 2018 - 2024, (USD Million)
  • TABLE 21 Enteral nutrition market, 2025 - 2032, (USD Million)
  • TABLE 22 Standard composition market, 2018 - 2024, (USD Million)
  • TABLE 23 Standard composition market, 2025 - 2032, (USD Million)
  • TABLE 24 Disease specific composition market, 2018 - 2024, (USD Million)
  • TABLE 25 Disease specific composition market, 2025 - 2032, (USD Million)
  • TABLE 26 Parenteral nutrition market, 2018 - 2024, (USD Million)
  • TABLE 27 Parenteral nutrition market, 2025 - 2032, (USD Million)
  • TABLE 28 Amino acids market, 2018 - 2024, (USD Million)
  • TABLE 29 Amino acids market, 2025 - 2032, (USD Million)
  • TABLE 30 Fats market, 2018 - 2024, (USD Million)
  • TABLE 31 Fats market, 2025 - 2032, (USD Million)
  • TABLE 32 Carbohydrates market, 2018 - 2024, (USD Million)
  • TABLE 33 Carbohydrates market, 2025 - 2032, (USD Million)
  • TABLE 34 Others market, 2018 - 2024, (USD Million)
  • TABLE 35 Others market, 2025 - 2032, (USD Million)
  • TABLE 36 Pediatric market, 2018 - 2024, (USD Million)
  • TABLE 37 Pediatric market, by region, 2025 - 2032, (USD Million)
  • TABLE 38 Adult market, 2018 - 2024, (USD Million)
  • TABLE 39 Adult market, 2025 - 2032, (USD Million)
  • TABLE 40 Cancer market, 2018-2024, (USD Million)
  • TABLE 41 Cancer market, 2025-2032, (USD Million)
  • TABLE 42 Metabolic disorders market, 2018-2024, (USD Million)
  • TABLE 43 Metabolic disorders market, 2025-2032, (USD Million)
  • TABLE 44 Neurological diseases market, 2018-2024, (USD Million)
  • TABLE 45 Neurological diseases market, 2025-2032, (USD Million)
  • TABLE 46 Gastrointestinal disorders market, 2018-2024, (USD Million)
  • TABLE 47 Gastrointestinal disorders market, 2025-2032, (USD Million)
  • TABLE 48 Others market, 2018-2024, (USD Million)
  • TABLE 49 Others market, 2025-2032, (USD Million)
  • TABLE 50 Retail stores market, 2018-2024, (USD Million)
  • TABLE 51 Retail stores market, 2025-2032, (USD Million)
  • TABLE 52 Pharmacies and drug stores market, 2018-2024, (USD Million)
  • TABLE 53 Pharmacies and drug stores market, 2025-2032, (USD Million)
  • TABLE 54 Online channels market, 2018-2024, (USD Million)
  • TABLE 55 Online channels market, 2025-2032, (USD Million)
  • TABLE 56 Others market, 2018-2024, (USD Million)
  • TABLE 57 Others market, 2025-2032, (USD Million)
  • TABLE 58 Powder market, 2018-2024, (USD Million)
  • TABLE 59 Powder market, 2025-2032, (USD Million)
  • TABLE 60 Liquid market, 2018-2024, (USD Million)
  • TABLE 61 Liquid market, 2025-2032, (USD Million)
  • TABLE 62 Solid market, 2018-2024, (USD Million)
  • TABLE 63 Solid market, 2025-2032, (USD Million)

Charts & Figures

  • FIG. 1 GMI report coverage: Critical research elements
  • FIG. 2 Industry segmentation
  • FIG. 3 Top-down approach
  • FIG. 4 Market estimation and forecast methodology
  • FIG. 5 Market forecasting methodology
  • FIG. 6 Breakdown of primary participants
  • FIG. 7 Industry landscape, 2018 - 2032 (USD Million)
  • FIG. 8 Growth potential analysis, by product
  • FIG. 9 Growth potential analysis, by consumer
  • FIG. 10 Growth potential analysis, by application
  • FIG. 11 Growth potential analysis, by distribution channel
  • FIG. 12 Growth potential analysis, by dosage formulation
  • FIG. 13 Porter's analysis
  • FIG. 14 PESTEL analysis
  • FIG. 15 Company matrix analysis, 2022
  • FIG. 16 Strategy dashboard, 2022
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!